Protalix BioTherapeutics, Inc. Quarterly Current Ratio in % from Q1 2012 to Q2 2024

Taxonomy & unit
ratio: %
Description
The current ratio is a liquidity ratio that measures a company's ability to cover its short-term obligations with its current assets.
Summary
Protalix BioTherapeutics, Inc. quarterly Current Ratio history and growth rate from Q1 2012 to Q2 2024.
  • Protalix BioTherapeutics, Inc. Current Ratio for the quarter ending June 30, 2024 was 146 %, a 19.1% decline year-over-year.
Current Ratio, Quarterly (%)
Current Ratio, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date
Q2 2024 146 -34.6 -19.1% Jun 30, 2024
Q1 2024 175 +23.3 +15.4% Mar 31, 2024
Q4 2023 189 +41.2 +27.8% Dec 31, 2023
Q3 2023 189 +29.3 +18.3% Sep 30, 2023
Q2 2023 181 +12.8 +7.64% Jun 30, 2023
Q1 2023 152 +14 +10.2% Mar 31, 2023
Q4 2022 148 +21.7 +17.2% Dec 31, 2022
Q3 2022 160 +57.4 +56% Sep 30, 2022
Q2 2022 168 +69.7 +70.8% Jun 30, 2022
Q1 2022 138 +34.6 +33.6% Mar 31, 2022
Q4 2021 126 +22.8 +22% Dec 31, 2021
Q3 2021 102 -15.3 -13% Sep 30, 2021
Q2 2021 98.4 -14.6 -12.9% Jun 30, 2021
Q1 2021 103 -14.2 -12.1% Mar 31, 2021
Q4 2020 103 -24.5 -19.1% Dec 31, 2020
Q3 2020 118 -45.6 -28% Sep 30, 2020
Q2 2020 113 -80.9 -41.7% Jun 30, 2020
Q1 2020 117 -93.7 -44.4% Mar 31, 2020
Q4 2019 128 -98.5 -43.5% Dec 31, 2019
Q3 2019 163 -80.5 -33% Sep 30, 2019
Q2 2019 194 -37.1 -16% Jun 30, 2019
Q1 2019 211 -25 -10.6% Mar 31, 2019
Q4 2018 226 -26.2 -10.4% Dec 31, 2018
Q3 2018 244 +67.2 +38% Sep 30, 2018
Q2 2018 231 +22.4 +10.7% Jun 30, 2018
Q1 2018 236 -4.92 -2.04% Mar 31, 2018
Q4 2017 253 -30.5 -10.8% Dec 31, 2017
Q3 2017 177 -508 -74.2% Sep 30, 2017
Q2 2017 209 -298 -58.8% Jun 30, 2017
Q1 2017 241 -142 -37.2% Mar 31, 2017
Q4 2016 283 -3.81 -1.33% Dec 31, 2016
Q3 2016 684 +521 +320% Sep 30, 2016
Q2 2016 506 +329 +185% Jun 30, 2016
Q1 2016 383 +187 +95.8% Mar 31, 2016
Q4 2015 287 +71.3 +33.1% Dec 31, 2015
Q3 2015 163 -161 -49.7% Sep 30, 2015
Q2 2015 178 -176 -49.7% Jun 30, 2015
Q1 2015 196 -125 -39% Mar 31, 2015
Q4 2014 216 -77.7 -26.5% Dec 31, 2014
Q3 2014 324 +63.8 +24.5% Sep 30, 2014
Q2 2014 353 +127 +56.4% Jun 30, 2014
Q1 2014 321 +60 +23% Mar 31, 2014
Q4 2013 293 +15.9 +5.71% Dec 31, 2013
Q3 2013 260 -5.83 -2.19% Sep 30, 2013
Q2 2013 226 -22 -8.87% Jun 30, 2013
Q1 2013 261 +28.9 +12.5% Mar 31, 2013
Q4 2012 277 Dec 31, 2012
Q3 2012 266 Sep 30, 2012
Q2 2012 248 Jun 30, 2012
Q1 2012 232 Mar 31, 2012
* An asterisk sign (*) next to the value indicates that the value is likely invalid.